CIAM
CSTL icon

Caitong International Asset Management’s Castle Biosciences CSTL Stock Holding History

Caitong International Asset Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143 Buy
+6
New +$134 ﹤0.01% 2083
2026
Q1 		– Sell
-2,099
Closed -$81.7K – 2689
2025
Q4 		$81.7K Buy
2,099
+1,371
+188% +$44.2K 0.02% 513
2025
Q3 		$16.6K Buy
728
+622
+587% +$12.6K 0.01% 805
2025
Q2 		$2.17K Sell
106
-50
-32% -$926 ﹤0.01% 1362
2025
Q1 		$3.12K Buy
+156
New +$3.86K ﹤0.01% 1171

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitong International Asset Management's CSTL Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Castle Biosciences (CSTL) in Q2 2026: 6 shares worth $143. The stake represents ﹤0.01% of the portfolio and ranks #2083 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in CSTL as recently as Q4 2025.

Caitong International Asset Management first reported a position in CSTL in Q1 2025 and has held it in 5 quarters since. The position peaked at $81.7K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Caitong International Asset Management held 6 shares of Castle Biosciences worth $143 as of Q2 2026.
  • Castle Biosciences was a new Caitong International Asset Management position in Q2 2026.
  • Castle Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2083 holding.
  • Caitong International Asset Management first reported a position in Castle Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Castle Biosciences position peaked at $81.7K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.